brachytherapy systems prostate technology treatment planning civco ex3 stepper

November 21, 2013 — Civco Medical Solutions announced that its EX3 Stepper for low-dose rate (LDR) and high-dose rate (HDR) ultrasound-guided brachytherapy for prostate cancer detection and treatment received U.S. Food and Drug Administration (FDA) 510(k) clearance.
  
The EX3 Stepper’s modular design reports angular and linear position directly to the manufacturer’s treatment planning software intraoperatively. Through direct communication, the stepper offers rapid connection for data analysis and reduces clutter in the surgical suite. The unique design of the EX3 also features a removable electronic unit that mitigates the risk of damaging transmission components and reduces cleaning time after the procedure.
 
Civco’s EX3 Stepper, like its predecessor the EXII, offers compatibility for BK Medical, GE Healthcare, Hitachi Aloka and Siemens transrectal ultrasound probes, and it is currently validated for use with Varian Vitesse and VariSeed treatment planning software.
 
The EX3 has also received the CE mark the EX3 for sale in the European Union and other countries that recognize the CE mark.
 
For more information: www.civco.com

Related Content

News | Radiation Therapy

May 1, 2024 — Sun Nuclear, a Mirion Medical company, today announced the upcoming version 5.0 release of its SunCHECK ...

Time May 01, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Radiation Therapy

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
Feature | Radiation Oncology | By Melinda Taschetta-Millane

In a new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS ...

Time April 10, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
News | Artificial Intelligence

March 21, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care ...

Time March 21, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Subscribe Now